Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Team
1–2
French register · Dec 2024
Backers
1
IncubAlliance
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 13, 2024
Founded per the company register
Registers and programsofficial lists and records that name the company
| Legal entity | HARMONIX | recherche-entreprises |
| Registered | 13 Mar 2024 |
Founders and leadersfrom filings, registers and the company's site
Delphine Quentin De Gromard GalezowskiPrésident de SAScompany register
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers

Capsida Biotherapeutics is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies…

GENE THERAPY.FOR SIGHT.. L E A R N M O R E.

On this page Key figures Home > Who we are > Company Our mission is to turn scientific advances in gene therapy into novel treatments for…

GeneVentiv Therapeutics — advancing gene therapy approaches.

Cell and Gene Therapy. Cure Genetics Committed to the development of gene and cell therapy for oncology and genetic diseases Cure Genetics…

Borea therapeuticsBorea Therapeutics: Next-generation viral vectors for targeted gene therapy.
People

Delphine Quentin De Gromard Galezowski
Président de SAS
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Orléans
France
HQ
1 Avenue du Champ de Mars, Orléans, CVL, 45100, FR

IncubAlliance 




